科济生物医药（上海）有限公司 CARSGEN THERAPEUTICS CO LTD
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
CARsgen Therapeutics Receives IND Clearance for GPC3-CAR-T Cells from the NMPA 2019-01-29 18:00
CARsgen Presents Preliminary Results of CAR-BCMA T Cell Therapy at ASH 2018 2018-12-04 20:00
CARsgen Appoints Dr. Hong MA as Senior Vice President of Clinical Development 2018-08-27 21:00
CARsgen Completed $60 Million Pre-C Financing Framework Agreements 2018-03-02 14:00
CARsgen Launches First-in-Class Anti-Claudin18.2 CAR-T Clinical Trial 2017-08-10 14:10
CARsgen Therapeutics Joins The Alliance for Regenerative Medicine 2017-06-30 19:57
CARsgen Therapeutics Presented at the 2017 BIO International Convention 2017-06-23 12:00
CARsgen Presents Phase I Results of CAR-GPC3 T HCC Trial at ASCO 2017 Annual Meeting 2017-06-05 14:30
CARsgen Therapeutics Opens CAR T-cell Manufacturing Facility in Shanghai 2017-05-03 19:15
CARsgen Therapeutics Completes $30 Million Series B Financing 2016-01-25 23:00
CARsgen Enters into Partnership Agreement with Shanghai Cancer Institute to Develop Novel CAR-T Technology 2015-09-29 22:00
1 2